Добірка наукової літератури з теми "Matrix Metalloproteinase 2 (MMP2)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Matrix Metalloproteinase 2 (MMP2)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Matrix Metalloproteinase 2 (MMP2)"
Balasa, Rodica, Ciurba Bianca, Voidezan Septimiu, Simu Iunius, Hutanu Adina, Andone Sebastian, Romaniuc Andreea, Motataianu Anca, and Maier Smaranda. "The Matrix Metalloproteinases Panel in Multiple Sclerosis Patients Treated with Natalizumab: A Possible Answer to Natalizumab Non- Responders." CNS & Neurological Disorders - Drug Targets 17, no. 6 (August 28, 2018): 464–72. http://dx.doi.org/10.2174/1871527317666180703102536.
Повний текст джерелаBartnykaitė, Agnė, Aistė Savukaitytė, Justina Bekampytė, Rasa Ugenskienė, Danguolė Laukaitienė, Erika Korobeinikova, Jurgita Gudaitienė, and Elona Juozaitytė. "The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer." Biomedicines 10, no. 8 (August 4, 2022): 1891. http://dx.doi.org/10.3390/biomedicines10081891.
Повний текст джерелаYang, Hui, Carlos E. Bueso-Ramos, Sherry A. Pierce, Yue Wei, Zhihong Fang, Martin Nguyen, Michael Fernadez, Marylou Cardenas-Turanzas, Hagop M. Kantarjian, and Guillermo Garcia-Manero. "Expression Profiles of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases (TIMPs) in Myelodysplastic Syndromes (MDS): Level of MMP-9 Is Associated with Improved Prognosis in MDS Patients." Blood 120, no. 21 (November 16, 2012): 3845. http://dx.doi.org/10.1182/blood.v120.21.3845.3845.
Повний текст джерелаCoven, İlker, Ozge Ozer, Ozlem Ozen, Feride İffet Şahin, and Nur Altinors. "Presence of matrix metalloproteinase–2 and tissue inhibitor matrix metalloproteinase–2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas." Journal of Neurosurgery 121, no. 6 (December 2014): 1478–82. http://dx.doi.org/10.3171/2014.8.jns13515.
Повний текст джерелаWIPFF, JULIEN, PHILIPPE DIEUDE, JEROME AVOUAC, KIET TIEV, ERIC HACHULLA, JEAN-LUC CRACOWSKI, ELIZABETH DIOT, et al. "Association of Metalloproteinase Gene Polymorphisms with Systemic Sclerosis in the European Caucasian Population." Journal of Rheumatology 37, no. 3 (January 28, 2010): 599–602. http://dx.doi.org/10.3899/jrheum.090973.
Повний текст джерелаDetry, Benoit, Charlotte Erpicum, Jenny Paupert, Silvia Blacher, Catherine Maillard, Françoise Bruyère, Hélène Pendeville, et al. "Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase." Blood 119, no. 21 (May 24, 2012): 5048–56. http://dx.doi.org/10.1182/blood-2011-12-400267.
Повний текст джерелаRen, Xiaoyu, Graham D. Lamb, and Robyn M. Murphy. "Distribution and activation of matrix metalloproteinase-2 in skeletal muscle fibers." American Journal of Physiology-Cell Physiology 317, no. 3 (September 1, 2019): C613—C625. http://dx.doi.org/10.1152/ajpcell.00113.2019.
Повний текст джерелаSultan, Baqur A., and Raad Ajam Sayhel Al.Jorany. "Evaluation of Matrix Metalloproteinase-2 (MMP2) in Aborted Women Infected with Toxoplasma gondii." Kufa Journal for Nursing Sciences 6, no. 2 (August 29, 2016): 122–29. http://dx.doi.org/10.36321/kjns.vi20162.2704.
Повний текст джерелаKan, Taichi, Hiromi Ueda, Taishi Takahara, Yoshimasa Tsuchiya, Mayuko Kishimoto, Yasue Uchida, Tetsuya Ogawa, Wataru Ohashi, Toyonori Tsuzuki, and Yasushi Fujimoto. "Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma." BioMed Research International 2021 (March 10, 2021): 1–8. http://dx.doi.org/10.1155/2021/6644897.
Повний текст джерелаZhang, Jianmei, Mi-Yeon Kim, and Jae Youl Cho. "Euodia pasteuriana Methanol Extract Exerts Anti-Inflammatory Effects by Targeting TAK1 in the AP-1 Signaling Pathway." Molecules 25, no. 23 (December 7, 2020): 5760. http://dx.doi.org/10.3390/molecules25235760.
Повний текст джерелаДисертації з теми "Matrix Metalloproteinase 2 (MMP2)"
Teh, Elaine. "Matrix metalloproteinase-2 (MMP2) and myocardial dysfunction associated with urgent cardiac surgery." Thesis, King's College London (University of London), 2013. https://kclpure.kcl.ac.uk/portal/en/theses/matrix-metalloproteinase2-mmp2-and-myocardial-dysfunction-associated-with-urgent-cardiac-surgery(de82119f-7ae0-4131-a743-03a8d168b62a).html.
Повний текст джерелаKuittinen, O. (Outi). "Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in hematological malignancies." Doctoral thesis, University of Oulu, 2003. http://urn.fi/urn:isbn:951426942X.
Повний текст джерелаCoughlan, Andrew Richard. "Matrix metalloproteinase (MMP) 2 and 9 in canine arthritis." Thesis, University of Liverpool, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.243201.
Повний текст джерелаGuo, Chung. "Divergent regulation of MMP-2 secretion and activation in adult rat cardiac fibroblasts." Thesis, De Montfort University, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.247642.
Повний текст джерелаBergman, Robert Loring. "Matrix Metalloproteinases 2 and 9 in Normal Canine Cerebrospinal Fluid." Thesis, Virginia Tech, 2001. http://hdl.handle.net/10919/33750.
Повний текст джерелаMaster of Science
Renaud, Virginie. "Étude de la voie de présentation de l'antigène MMP-2 par les cellules tumorales." Nantes, 2009. http://www.theses.fr/2009NANT2099.
Повний текст джерелаFrom a patient still melanoma free after TIL injection, we characterized a new tumor antigen, MMP-2, recognized by a CD8 T cell clone in HLA-A*0201 context. Surprisingly melanoma cell lines present this tumor antigen by the cross presentation pathway (Godefroy & al. , 2005). In the first part, we wondered if disulfide bonds present in MMP-2 were not responsible for its absence of presentation by the endogenous pathway. By mutagenesis, we replaced a cystein by an alanine in the cDNA coding for MMP-2, in order to induce a disulfide bond deletion and then we transfected these cDNA mutants in COS-7 and human tumor cell lines. We showed that MMP-2 deletion of one disulfide bond induce its presentation by the endogenous pathway. By pulse chase experiments we also demonstrated that MMP-2 mutated form is more rapidly degraded than the wild form. MMP-2 folding and consequently conformation seems to play an important role in the absence of its presentation by the classical pathway. In the second part, we try to determine intracellular pathway implicated in MMP-2 cross-presentation in melanoma cells. Indeed, after secretion, MMP-2 is internalized by melanoma cells in an v3 dependent manner and by an unknown pathway. MMP-2 is finally processed by the proteasome and loaded on MHC class I molecule (Godefroy & al. , 2005). By using drugs, we determined that MMP-2 cross-presentation involves the retrotranslocation machinery, the proteasome and TAP, all implicated in the endogenous pathway. To determine compartments necessary to MMP-2 cross-presentation we tested Organelles lights (Invitrogen). These reagents provide a method for targeted specific subcellular structures within living cells
Kuntze, Luciana Bärg. "Efeito inibitório do captopril sobre a Metaloproteinase-2 da Matriz Extracelular (MMP-2) in vitro." Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/17/17133/tde-27072016-160209/.
Повний текст джерелаMMP-2 is involved in many physiological and pathological processes. This protease shares structural similarities with the angiotensin-converting enzyme (ACE), and ACE inhibitors have been described to inhibit MMP-2. However, this inhibitory potential has not been tested using a highly purified MM-2 so far. This study aimed at investigating the inhibitory potential of captopril on MMP-2 activity. First it was tested whether the dissolution of captopril would induce changes in the pH of the solutions. Secondly, the direct inhibitory effect of captopril on plasma MMP-2 and on a recombinant human MMP-2 (rhMMP-2) produced and purified from E. coli was tested. The in vitro activity assays included gelatin zymography and a fluorimetric assay with DQ gelatin. Captopril solubilization significantly decreased the pH of the 50 mM Tris buffer solution (p<0.01) but did not decreased the pH of the 200 mM Tris Buffer solution (p>0.05). Zymography results of plasma and rhMMP-2 showed that inhibition of the activity only reached statistical significance >= 4 and 1 mM of captopril, respectively (p<0,05). The presence of captopril in the fluorimetric assay resulted in a significant inhibition of the rhMMP-2 activity only at concentrations >= 2 mM (p<0.01), whereas APMA-activated rhMMP-2 was inhibited by 0.5 mM of captopril (p<0.01). The captopril concentrations found to inhibit MMP-2 are several times of magnitude higher than the maximum plasma concentration after a dose of 50 mg of captopril. In conclusion, captopril does not seem to cause significant inhibition of MMP-2 in the concentrations found in vivo, and more attention has to be given to the pH of the solutions when testing protease inhibition in vitro.
Vasala, K. (Kaija). "Matrix metalloproteinase MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in bladder carcinoma." Doctoral thesis, University of Oulu, 2008. http://urn.fi/urn:isbn:9789514288746.
Повний текст джерелаKim, Yu Shin. "Correlation Between MMP-2 and -9 Levels and Local Stresses in Arteries Using a Heterogeneous Mechanical Model." Diss., Georgia Institute of Technology, 2007. http://hdl.handle.net/1853/16134.
Повний текст джерелаFarooqi, Owais Ali. "Effect of methamphetamine on gingival fibroblast production of matrix metalloproteinase (MMP)-2 and -9 and tissue inhibitor of metalloproteinase (TIMP)-1 and -2 in vitro." View the abstract Download the full-text PDF version, 2009. http://etd.utmem.edu/ABSTRACTS/2009-023-Farooqi-index.htm.
Повний текст джерелаTitle from title page screen (viewed on August 5, 2009). Research advisor: David A. Tipton, D.D.S., Ph.D. Document formatted into pages (vi, 39 p. : ill.). Vita. Abstract. Includes bibliographical references (p. 27-38).
Книги з теми "Matrix Metalloproteinase 2 (MMP2)"
Yeung, Oliver. Differential regulation of matrix metalloproteinase-2 (MMP-2) by phorbol myrisate acetate, and by DL-[alpha]-difluoromethylornithine, in cell lines of varying tumorigenic and metastatic potential. Ottawa: National Library of Canada, 1999.
Знайти повний текст джерелаBaragwanath, Philip. Matrix metalloproteinase-2 and -9 in human wound healing. Birmingham: University of Birmingham, 2000.
Знайти повний текст джерелаЧастини книг з теми "Matrix Metalloproteinase 2 (MMP2)"
Salajegheh, Ali. "Matrix Metalloproteinase 2 (MMP2)." In Angiogenesis in Health, Disease and Malignancy, 203–8. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-28140-7_31.
Повний текст джерелаHinterseher, I., D. Krex, D. Ockert, E. Kuhlisch, H. K. Schackert, and H. D. Saeger. "Analyse des Matrix Metalloproteinase-2 Genes (MMP-2) als ätiologischer Faktor spontaner Aortenaneurysmen." In Zurück in die Zukunft, 460–61. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-55611-1_280.
Повний текст джерелаHinterseher, Irene, D. Krex, D. Ockert, E. Kuhlisch, H. K. Schackert, and H. D. Saeger. "Genomische Analyse des Matrix Metalloproteinase-2 Gens (MMP-2) als potentieller ätiologischer Faktor spontaner Aortenaneurysmen." In Deutsche Gesellschaft für Chirurgie, 549–50. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-19024-7_151.
Повний текст джерелаSienel, W., R. Seen-Hibler, W. Wöckel, O. Thetter, W. Mutschler, and B. Passlick. "Die Überexpression von Matrix Metalloproteinase 2 (MMP-2) ist mit einer Frühdisseminierung bei operablem Adenokarzinom der Lunge assoziiert." In Deutsche Gesellschaft für Chirurgie, 93–95. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56698-1_24.
Повний текст джерелаLopes Barreto, Deirisa, and Raymond T. Krediet. "Matrix Metalloproteinase-2 (MMP-2) and Plasminogen Activator Inhibitor-1 (PAI-1) in Peritoneal Dialysis: Biological Implications and Clinical Utility." In Biomarkers in Kidney Disease, 911–30. Dordrecht: Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-007-7699-9_25.
Повний текст джерелаLopes Barreto, Deirisa, and Raymond T. Krediet. "Matrix Metalloproteinase-2 (MMP-2) and Plasminogen Activator Inhibitor-1 (PAI-1) in Peritoneal Dialysis: Biological Implications and Clinical Utility." In Biomarkers in Kidney Disease, 1–20. Dordrecht: Springer Netherlands, 2015. http://dx.doi.org/10.1007/978-94-007-7743-9_25-1.
Повний текст джерелаChan, Brandon Y. H., Andrej Roczkowsky, Ramses Ilarraza, and Richard Schulz. "Matrix Metalloproteinase-2." In Encyclopedia of Signaling Molecules, 2996–3005. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_101708.
Повний текст джерелаChan, Brandon Y. H., Andrej Roczkowsky, Ramses Ilarraza, and Richard Schulz. "Matrix Metalloproteinase-2." In Encyclopedia of Signaling Molecules, 1–10. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4614-6438-9_101708-1.
Повний текст джерелаTyagi, Suresh C., Larry Meyer, Richard A. Schmaltz, Hanumanth K. Reddy, and Donald J. Voelker. "Proteinases and Restenosis: Matrix Metalloproteinase and their Inhibitor and Activator." In Cardiovascular Disease 2, 19–30. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1959-1_3.
Повний текст джерелаKalev-Altman, Rotem, Efrat Monsonego-Ornan, and Dalit Sela-Donenfeld. "The Role of Matrix Metalloproteinase-2 and Metalloproteinase-9 in Embryonic Neural Crest Cells and Their Derivatives." In Proteases in Physiology and Pathology, 27–48. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-2513-6_2.
Повний текст джерелаТези доповідей конференцій з теми "Matrix Metalloproteinase 2 (MMP2)"
Dutta, Anindita, Jing Li, Huimin Lu, Jacqueline Akech, Jitesh Pratap, Tao Wang, Thomas J. FitzGerald та ін. "Abstract C40: αvβ6 integrin promotes a TGFβ1-mediated cancer cell autonomous osteolytic program through upregulation of matrix metalloproteinase 2 (MMP2)". У Abstracts: AACR Special Conference on Tumor Invasion and Metastasis - January 20-23, 2013; San Diego, CA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tim2013-c40.
Повний текст джерелаRevilla Lopez, E. M., M. Boada, V. Ruiz De Miguel, S. Gomez Ollés, and B. Saez. "Exploring the role of matrix metalloproteinase 2 (MMP-2) as a biomarker in lymphangioleiomyomatosis." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.144.
Повний текст джерелаPitchford, Simon C., Stefania Momi, Clive P. Page, and Paolo Gresele. "The Role Of Platelet Matrix-Metalloproteinase 2 (MMP2) On Platelet And Leukocyte Migration Through Lung Tissue In A Murine Model Of Allergic Inflammation." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2784.
Повний текст джерелаStott-Miller, Marni, John Houck, Pawadee Lohavanichbutr, Stephen M. Schwartz, Melissa P. Upton, and Chu Chen. "Abstract 3819: Matrix metalloproteinase-1 (MMP1) is an important marker of oral squamous cell carcinoma." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3819.
Повний текст джерелаMudiyanselage, Chandana S. K. Herath, Neil Mitra, Dasuni Niyagama Gamage, Hiromichi Miyagaki, Abhinit Shah, Xiaohong Yan, Vesna Cekic, and Richard L. Whelan. "Abstract 1145: Assessing the diagnostic value of the combination of Matrix Metalloproteinase 2 (MMP2) and Progranulin (PGRN) preoperative plasma levels for colorectal cancer (CRC)." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-1145.
Повний текст джерелаSeccareccia, Erica, Shun Li, and Pnina Brodt. "Abstract 5255: The role of IGF1 signaling in site specific tumor metastasis: Regulating matrix metalloproteinase (MMP) expression." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-5255.
Повний текст джерелаSong, Nan, Hyuna Sung, Sujee Jeon, Yunhee Lee, Ji-Yeob Choi, Sue K. Park, Kyoung-Mu Lee, et al. "Abstract 4494: Preoperative serum levels of matrix metalloproteinase-2 (MMP-2) and survival of breast cancer among Korean women." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4494.
Повний текст джерелаNg, Ho Yin, Brian G. Oliver, Janette K. Burgess, Vera P. Krymskaya, Judith L. Black, and Lyn M. Moir. "Inhibition Of Matrix Metalloproteinase-2 (MMP-2) Decreases Migration Of TSC2-Null Mouse Embryonic Fibroblasts – Relevance To Pulmonary Lymphangioleiomyomatosis (LAM)." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3662.
Повний текст джерелаIto, Yusuke, Hitoshi Ishiguro, Naohito Kobayashi, Hisashi Hasumi, Masatoshi Watanabe, Masahiro Yao, and Hiroji Uemura. "Abstract 435: Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through matrix metalloproteinase (MMP-2) mediated extracellular matrix degradation." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-435.
Повний текст джерелаWang, Ying, John A. Johnson, Abigail Fulp, Michael A. Sutton, and Susan M. Lessner. "Adhesive Strength of Atherosclerotic Plaques Depends on Collagen Content." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80433.
Повний текст джерелаЗвіти організацій з теми "Matrix Metalloproteinase 2 (MMP2)"
Hernandez-Barrantes, Sonia, and Rafael Fridman. Extracellular Matrix Regulations of Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) and Matrix Metalloproteinase-2 (MMP-2) in Human Breast Fibroblasts. Fort Belvoir, VA: Defense Technical Information Center, August 2002. http://dx.doi.org/10.21236/ada413613.
Повний текст джерелаHernandez-Barrantes, Sonia, and Rafael Fridman. Extracellular Matrix Regulations of Membrane Type 1-Matrix Metalloproteinasis (MT1-MMP) and Matrix Metalloproteinase-2 (MMP-2) in Human Breast Fibroblasts. Fort Belvoir, VA: Defense Technical Information Center, August 2000. http://dx.doi.org/10.21236/ada395355.
Повний текст джерелаHarnandez-Barrantes, Sonia, and Rafael Fridman. Extracellular Matrix Regulations of Membrane Type 1 - Matrix Metalloproteinasis (MT1-MMP) and Matrix Metalloproteinase-2 (MMP-2) in Human Breast Fibroblasts. Fort Belvoir, VA: Defense Technical Information Center, August 2001. http://dx.doi.org/10.21236/ada396694.
Повний текст джерелаSamah, Nazirah, Azizah Ugusman, Adila A. Hamid, Nadiah Sulaiman, and Amilia Aminuddin. Role of matrix metalloproteinase-2 among coronary artery disease (CAD) patients: A systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2023. http://dx.doi.org/10.37766/inplasy2023.4.0058.
Повний текст джерела